Advertisement
Canada markets open in 7 hours 49 minutes
  • S&P/TSX

    22,346.76
    -121.40 (-0.54%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • DOW

    39,671.04
    -201.95 (-0.51%)
     
  • CAD/USD

    0.7309
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    77.00
    -0.57 (-0.73%)
     
  • Bitcoin CAD

    94,900.04
    -653.30 (-0.68%)
     
  • CMC Crypto 200

    1,511.54
    -14.88 (-0.97%)
     
  • GOLD FUTURES

    2,372.20
    -20.70 (-0.87%)
     
  • RUSSELL 2000

    2,081.71
    -16.65 (-0.79%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • NASDAQ futures

    18,951.25
    +164.50 (+0.88%)
     
  • VOLATILITY

    12.29
    +0.43 (+3.63%)
     
  • FTSE

    8,370.33
    -46.12 (-0.55%)
     
  • NIKKEI 225

    39,065.48
    +448.38 (+1.16%)
     
  • CAD/EUR

    0.6748
    +0.0003 (+0.04%)
     

Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say

Perrigo (PRGO) reported $1.08 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 8.4%. EPS of $0.29 for the same period compares to $0.45 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.09 billion, representing a surprise of -0.91%. The company delivered an EPS surprise of +20.83%, with the consensus EPS estimate being $0.24.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Perrigo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Consumer Self-Care Americas (CSCA): $644.10 million versus the three-analyst average estimate of $653.51 million. The reported number represents a year-over-year change of -15.7%.

  • Net Sales- Consumer Self-Care International (CSCI): $437.90 million versus the three-analyst average estimate of $438.50 million. The reported number represents a year-over-year change of +4.7%.

  • Net Sales- CSCA- Oral care: $64.70 million versus $78.21 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -23.3% change.

  • Net Sales- CSCA- Nutrition: $90.60 million compared to the $42.89 million average estimate based on two analysts. The reported number represents a change of -35.2% year over year.

  • Net Sales- CSCA- Healthy Lifestyle: $71.30 million versus $75.24 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change.

  • Net Sales- CSCA- Upper Respiratory: $130.30 million compared to the $151.22 million average estimate based on two analysts. The reported number represents a change of -15.6% year over year.

  • Gross Profit- Consumer Self-Care International- Adjusted (CSCI): $232.30 million versus the three-analyst average estimate of $217.16 million.

  • Gross Profit- Consumer Self-Care Americas- Adjusted (CSCA): $163.20 million versus $194.01 million estimated by three analysts on average.

View all Key Company Metrics for Perrigo here>>>

Shares of Perrigo have returned +5.3% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Perrigo Company plc (PRGO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research